Product NDC: | 0555-1010 |
Proprietary Name: | Clonidine |
Non Proprietary Name: | Clonidine |
Active Ingredient(s): | .2 mg/24h & nbsp; Clonidine |
Administration Route(s): | TRANSDERMAL |
Dosage Form(s): | PATCH, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0555-1010 |
Labeler Name: | Barr Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA079090 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100825 |
Package NDC: | 0555-1010-16 |
Package Description: | 4 POUCH in 1 CARTON (0555-1010-16) > 1 PATCH in 1 POUCH > 24 h in 1 PATCH |
NDC Code | 0555-1010-16 |
Proprietary Name | Clonidine |
Package Description | 4 POUCH in 1 CARTON (0555-1010-16) > 1 PATCH in 1 POUCH > 24 h in 1 PATCH |
Product NDC | 0555-1010 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clonidine |
Dosage Form Name | PATCH, EXTENDED RELEASE |
Route Name | TRANSDERMAL |
Start Marketing Date | 20100825 |
Marketing Category Name | ANDA |
Labeler Name | Barr Laboratories Inc. |
Substance Name | CLONIDINE |
Strength Number | .2 |
Strength Unit | mg/24h |
Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |